Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infantile Respiratory Distress Syndrome

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Infantile Respiratory Distress Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoffman, DR; Johnston, JM; Moya, FR; Zhao, B1
Caplan, MS1
Johno, M; Murakami, K; Okabe, H; Okajima, K; Takatsuki, K; Uchiba, M1
Bambang, SO; Brus, F; Okken, A; van Oeveren, W1
Lefferts, PL; Lu, W; Snapper, JR; Thabes, JS1
Koyama, N; Ogawa, Y1

Other Studies

6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infantile Respiratory Distress Syndrome

ArticleYear
Platelet-activating factor in surfactant preparations.
    Lancet (London, England), 1993, Apr-03, Volume: 341, Issue:8849

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phospholipases A; Phospholipids; Phosphorylcholine; Platelet Activating Factor; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Trachea

1993
PAF and surfactant preparations.
    Lancet (London, England), 1993, Apr-03, Volume: 341, Issue:8849

    Topics: Animals; Humans; Infant, Newborn; Platelet Activating Factor; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1993
A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats.
    Thrombosis and haemostasis, 1996, Volume: 75, Issue:6

    Topics: Animals; Blood Coagulation; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Female; Humans; Infant, Newborn; Platelet Activating Factor; Pulmonary Artery; Rats; Rats, Wistar; Respiratory Distress Syndrome, Newborn; Thiazoles; Thiazolidines

1996
Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome.
    Pediatric research, 1996, Volume: 39, Issue:3

    Topics: alpha 1-Antitrypsin; Complement C3a; Female; Humans; Infant, Newborn; Leukocyte Count; Leukocyte Elastase; Lymphocyte Activation; Male; Neutrophils; Obstetric Labor, Premature; Platelet Activating Factor; Pregnancy; Respiratory Distress Syndrome, Newborn; Tumor Necrosis Factor-alpha; Ventilators, Mechanical

1996
Effect of platelet-activating factor-receptor antagonism on endotoxin-induced lung dysfunction in sheep.
    Journal of applied physiology (Bethesda, Md. : 1985), 1998, Volume: 84, Issue:5

    Topics: Animals; Blood Pressure; Endotoxins; Humans; Infant, Newborn; Leukocyte Count; Lung; Oxygen; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prodrugs; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Sheep; Thiazoles

1998
Elevated platelet activating factor in the tracheal aspirate at birth and signs of intra-uterine inflammation in infants with neonatal pulmonary emphysema.
    European journal of pediatrics, 1999, Volume: 158, Issue:10

    Topics: Bronchoalveolar Lavage Fluid; Female; Fetal Diseases; Humans; Immunoglobulin M; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Leukocyte Count; Neutrophils; Platelet Activating Factor; Pulmonary Emphysema; Respiratory Distress Syndrome, Newborn; Trachea

1999